|
|
|
|
Division Faculty
 K. B. Ramanathan, MD
Title:
Professor of Medicine
Co-Program Director, Cardiology Fellowship Program
University of Tennessee Health Science Center
Chief of Cardiology
Director, Cardiac Catheterization Lab
Veterans Affairs Medical Center (Memphis)
Contact Information:
Email: Kodangudi.Ramanathan@va.gov
Office: (901) 577-7355
Clinical/Research Interests:
Interventional cardiology, IVUS, stents, critical care.
Coronary collateral circulation, ventricular pressure/volume relationships and left ventricular function in diabetes mellitus, beta-blockade in congestive heart failure and atrial fibrillation, revascularization in unstable angina, and risk factors for coronary disease and cardiac function in muscular dystrophy. Investigator in several major VA clinical trials.
Recent Publications:
- Ramanathan KB, Weiman DS, Sacks J, Morrison DA, Sedlis S, Sethi G, Henderson WG. Percutaneous intervention versus coronary bypass surgery for patients older than 70 years of age with high-risk unstable angina. Ann Thorac Surg. 2005;80:1340-1346.
- Campos PC, D'Cruz IA, Johnson LS, Malhotra A, Ramanathan KB, Weber KT. Functional valvular incompetence in decompensated heart failure: noninvasive monitoring and response to medical management. Am J Med Sci. 2005;329:217-221.
- Sedlis SP, Ramanathan KB, Morrison DA, Sethi G, Sacks J, Henderson W. Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry). Am J Cardiol. 2004;94:118-120.
- Saucedo JF, Garza L, Wolford DC, Cook SL, Ramanathan KB, Matin Z, McGrew FA, Jacoski MV, Jennings LK. Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study). Am J Cardiol. 2004;93:1279-1282.
- Akhtar A, D'Cruz IA, Ramanathan KB, Umpierrez M. Diffuse locally invasive lipomatosis of the pericardium. Echocardiography. 2003;20:173-177.
- Sedlis SP, Morrison DA, Lorin JD, Esposito R, Sethi G, Sacks J, Henderson W, Grover F, Ramanathan KB, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Murphy E, Ward H, Miller L, Kiesz S, Barbiere C, Lewis D. Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol. 2002;40:1555-1566.
- Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R, Ramanathan KB, Weiman D, Talley JD, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Barbiere C, Lewis D. Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol. 2002;39:266-273.
- Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R, Ramanathan K, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Barbiere C, Lewis D. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol. 2001;38:143-149.
- Ramanathan KB, Horn HR. Anticoagulation for the patient with valvular heart disease and atrial fibrillation. In: Alpert JS, Dalen JE, Rahimtoola S, eds. Valvular Heart Disease. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins, 2000:455-464.
- Morrison DA, Sethi G, Sacks J, Grover F, Sedlis S, Esposito R, Ramanathan KB, Weiman D, Krucoff M, Duhaylongsod F, Raya T, Pett S, Vernon S, Birjiniuk V, Booth D, Robinson C, Talley JD, Antckli T, Murphy E, Floten H, Curcovic V, Lucke JC, Lewis D, Barbiere C, Henderson W. A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans Affairs. Control Clin Trials. 1999;20:601-619.
|
|
